for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Joincare Pharmaceutical Group Ind. Co.

600380.SS

Latest Trade

9.71CNY

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

6.28

 - 

10.03

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
9.71
Open
--
Volume
--
3M AVG Volume
233.58
Today's High
--
Today's Low
--
52 Week High
10.03
52 Week Low
6.28
Shares Out (MIL)
1,938.03
Market Cap (MIL)
18,314.42
Forward P/E
21.64
Dividend (Yield %)
1.69

Latest Developments

More

Joincare Pharmaceutical Group Says H1 Net Profit Up 28.3% Y/Y

Joincare Pharmaceutical's Q1 Net Profit Up 35.3 Percent Y/Y

Joincare Pharmaceutical's 2018 Net Profit Down 67.2 Pct Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Joincare Pharmaceutical Group Ind. Co.

Joincare Pharmaceutical Group Industry Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals and healthcare products. The Company's products include chemical materials and intermediates, chemical agents, health products, traditional Chinese medicines, diagnostic reagents and equipment. The Company is also engaged in electricity business. The Company distributes its products within domestic market and to overseas markets.

Industry

Biotechnology & Drugs

Contact Info

Joincare Pharmaceutical Group Plaza

No.17 Langshan Road, North Section

High-Tech Zone, Nanshan District

+86.755.86252388

http://www.joincare.com

Executive Leadership

Baoguo Zhu

Chairman of the Board

Guangxia Liu

Vice Chairman of the Board

Pingwei Cao

Finance Director, Deputy General Manager, Director

Qingfeng Qiu

Deputy General Manager, Secretary of the Board, Director

Yanfang Feng

Independent Director

Key Stats

1.67 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2018

11.2K

2019(E)

12.6K
EPS (CNY)

2019(E)

0.437
Price To Earnings (TTM)
21.63
Price To Sales (TTM)
1.56
Price To Book (MRQ)
1.82
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
23.69
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
17.11
Return on Equity (TTM)
7.52

Latest News

BRIEF-Livzon Pharmaceutical Group To Sell 51% Stake In Livzon Mab To Biologics Ltd

* APPROVED TRANSACTION IN RESPECT OF CHANGE IN SHAREHOLDING STRUCTURE OF LIVZON MABPHARM INC

BRIEF-Livzon Pharmaceutical Group Says Joincare To Sell 49 PCT Equity Interests In Livzon Mab

* PROPOSES TO ENTER AGREEMENT PURSUANT TO WHICH JOINCARE TO SELL 49% EQUITY INTERESTS IN LIVZON MAB FOR RMB294 MILLION Source text for Eikon: Further company coverage:

BRIEF-Joincare Pharma plans share issue to fund projects

Joincare Pharmaceutical Group Industry Co Ltd

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up